Glioblastoma is a dangerous brain tumor known for its fast growth and insensitivity to conventional treatments. Investigations are constantly underway to identify new management strategies, and recently, a unique biomarker named LCA168 has emerged as a potential focus for glioblastoma treatment. LCA168 is a protein that is overexpressed in gliobla